ProCE Banner Activity

Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

Slideset

Download this slideset from a live meeting series for the multidisciplinary team to get up to date on the latest clinical data informing optimal use of novel therapies in the treatment of advanced HR+/HER2- high-risk early breast cancer and metastatic breast cancer, including management of key adverse events associated with novel agents.

Released: January 12, 2024

Expiration: January 11, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly